Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
A939572
Cat. No.:
OB0225LY-0221
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
A939572 is a highly selective immunomodulator, mainly used to study cell signaling and immune responses.
Synonym:
1032229-33-6; 4-(2-Chlorophenoxy)-N-[3-(methylcarbamoyl)phenyl]piperidine-1-carboxamide; 4-(2-Chlorophenoxy)-N-(3-(methylcarbamoyl)phenyl)piperidine-1-carboxamide; 1-Piperidinecarboxamide,4-(2-chlorophenoxy)-N-[3-[(methylamino)carbonyl]phenyl]-; (Z)-4-(2-Chlorophenoxy)-N-(3-((Z)-hydroxy(methylimino)methyl)phenyl)piperidine-1-carbimidic acid
CAS No.:
1032229-33-6
Compound CID:
24905400
Formula:
C20H22ClN3O3
Formula Weight:
387.86
Specification
Relative Density:
1.302 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
A939572 can be used in immune system research or play an important role in autoimmune disease modeling.
Library Information
Targets:
Dehydrogenase; Stearoyl-CoA desaturase (SCD) family
Receptors:
SCD1
Pathways:
Metabolism
Plate Number:
AOCL-3
Plate Location:
g5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
45 mg/mL; 116.02 mM
